Lyell Immunopharma LYEL
NASDAQ LYEL
$16.86 +0.11 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Lyell Immunopharma (LYEL) Preferred Dividend Payments (2020 - 2021)

Updated

Lyell Immunopharma's Preferred Dividend Payments was $3.58 million in FY2020, up 213.1% from $1.14 million in FY2019.

Analysis

Lyell Immunopharma (LYEL) Preferred Dividend Payments (2020 - 2021) Analysis & Trends

  • Per Business Quant data, Preferred Dividend Payments in earlier years was $1.14 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Lyell Immunopharma 411.74 Mn -470.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -3.58 Mn
Dec 31, 2020 7.16 Mn
API Access

Lyell Immunopharma Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=LYEL&period=max&api_key=YOUR_API_KEY